What Is the Hantavirus? The 2026 Outbreak Explained

With the MV Hondius cruise ship cluster dominating international headlines — 14 confirmed cases across 11 countries as of May 15, 2026 — millions of people are asking for the first time: what is the hantavirus, exactly? This guide answers that question from first principles and explains what makes the current outbreak different.

What Is Hantavirus?

Hantavirus is a group of RNA viruses belonging to the family Hantaviridae, order Bunyavirales. Unlike many viral pathogens, hantaviruses are primarily rodent-borne: each virus species co-evolved with a specific rodent host, in which it causes a persistent but asymptomatic infection.

Humans become infected when they inhale microscopic aerosol particles contaminated with the urine, droppings, or saliva of an infected rodent. This is not a virus that spreads between people in the ordinary course of daily life — with one important exception discussed below.

Key facts at a glance

Feature	Detail
Family	Hantaviridae (RNA virus, enveloped)
Genome	Tripartite negative-sense RNA
Main reservoir	Wild rodents (genus Peromyscus, Oligoryzomys, Apodemus, others)
Primary route to humans	Aerosol inhalation of rodent excreta
Incubation period	1–8 weeks (typically 2–4 weeks)
Person-to-person	Rare — only Andes virus has documented P2P transmission
Treatment	Supportive care; no approved antiviral

The Two Main Disease Syndromes

When humans are infected, hantavirus causes one of two serious syndromes depending on the viral species involved:

1. Hantavirus Pulmonary Syndrome (HPS) — the Americas

Andes virus (South America) and Sin Nombre virus (North America) cause HPS, a severe respiratory illness. The virus attacks the capillaries lining the lungs, causing them to leak fluid into the airspace — essentially a rapid-onset non-cardiogenic pulmonary oedema.

Case fatality rate: 20–40% for Sin Nombre; ~30% for Andes
Geographic range: North and South America, primarily Patagonia and the US Southwest
Classic presentation: Flu-like prodrome (fever, myalgia), then sudden respiratory failure within hours

2. Haemorrhagic Fever with Renal Syndrome (HFRS) — Europe and Asia

Hantaan, Seoul, Puumala, and Dobrava viruses cause HFRS, affecting the kidneys rather than the lungs. Europeans are most familiar with Puumala virus, which causes a milder condition known as nephropathia epidemica.

Case fatality rate: 0.1–1% for Puumala; up to 12% for Hantaan
Geographic range: Europe, Russia, Korea, China, Japan
Classic presentation: Fever, back pain, renal failure; haemorrhagic manifestations in severe cases

What Is the Hantavirus Doing in 2026?

The 2026 outbreak is unlike any previous hantavirus event in one critical respect: it started on a cruise ship in the remote waters of Antarctica and has since spread across 11 countries as passengers returned home.

The MV Hondius timeline

March 20, 2026 — MV Hondius departs Ushuaia, Argentina, on an Antarctic expedition voyage carrying approximately 200 passengers of 13 nationalities.
~April 15 — First passenger develops symptoms; evacuated to hospital.
April 26 — Second death.
May 2 — WHO formally notified; RT-PCR confirms hantavirus in multiple samples.
May 4 — Three deaths confirmed.
May 10 — All passengers disembarked in Tenerife; vessel enters decontamination.
May 14 — France confirms first person-to-person (P2P) Andes transmission in the Lyon household of a returning passenger. ECDC upgrades EU/EEA risk to HIGH.
May 15 — Germany confirms 14th case; the last monitored Hondius contact tests positive. WHO extends household contact monitoring to 60 days. Nature Medicine estimates Andes virus R₀ ≈ 0.5 in household settings — below the epidemic threshold.

Why Is Andes Virus Special?

Among the 40+ known hantavirus species, Andes virus stands out for one reason: it is the only hantavirus with documented person-to-person transmission. This was first established in Chilean and Argentine case clusters in the 1990s and 2000s, where household members and healthcare workers in close contact with patients developed disease without direct rodent exposure.

The Hondius outbreak has added a third line of evidence: the Lyon couple in France, confirmed by genomic analysis (viral sequences in both patients are essentially identical), represents the first P2P case outside South America.

However, the May 15 Nature Medicine correspondence is reassuring: the estimated household secondary attack rate remains around 10–15%, and the R₀ of approximately 0.5 means Andes virus cannot sustain person-to-person chains without continued environmental exposure. This is very different from a respiratory pathogen like influenza (R₀ ~1.3) or measles (R₀ ~15).

How Does Hantavirus Spread?

Understanding the transmission routes is essential for risk assessment:

Primary route — rodent aerosol

The overwhelming majority of hantavirus infections occur through:

Sweeping or disturbing dried rodent droppings (especially in enclosed spaces)
Cleaning buildings or storage areas where rodents have nested
Handling infected rodent carcasses without protection
Agricultural work in endemic areas

Secondary route — person-to-person (Andes virus only)

Andes virus P2P transmission is thought to occur through:

Respiratory droplets from symptomatic patients
Possible saliva contact in household settings
Not through casual contact, shared food, or airborne spread over distances

No healthcare worker has contracted Andes virus through routine patient care with standard PPE.

The Hondius scenario

Researchers believe passengers were exposed to rodent excreta found in below-deck cargo or storage areas during a shore excursion in Patagonia or the Antarctic Peninsula. Three of eleven confirmed below-deck areas tested positive for Andes virus RNA.

Who Is at Risk in 2026?

Group	Risk level	Reason
General public (no travel)	Very low	No community rodent reservoir changes
Tourists to Patagonia / US Southwest	Moderate	Endemic regions with seasonal risk
MV Hondius passengers	High (monitored)	Direct exposure; 60-day monitoring
Household contacts of Hondius cases	Low–moderate	P2P risk; under active surveillance
Hikers / campers in endemic areas	Moderate	Aerosol exposure from disturbing rodent habitat

What Are the Symptoms?

HPS (Andes / Sin Nombre virus)

Prodromal phase (days 1–5):

Sudden high fever (38–40°C)
Severe muscle aches (back, thighs)
Fatigue, headache
Gastrointestinal symptoms (nausea, vomiting, diarrhoea) in 50%+

Cardiopulmonary phase (days 5–10):

Cough → breathlessness → respiratory failure
Fluid accumulates in the lungs
Hypotension, rapid heart rate
Oxygen saturation drops; intubation may be required

The window between prodrome and cardiopulmonary collapse can be as short as 24–48 hours — which is why early hospital evaluation is critical for anyone with potential exposure and fever.

Is There a Treatment or Vaccine?

No approved vaccine exists for any hantavirus as of 2026. Several investigational vaccines are in early clinical development (mRNA platforms; recombinant protein platforms), but none has completed Phase III trials.

No specific antiviral has demonstrated clear efficacy. Intravenous ribavirin has been used in HFRS with mixed results; it is not standard of care for HPS.

Treatment is therefore supportive, centred on:

Intensive care monitoring
Supplemental oxygen and mechanical ventilation if needed
Fluid management (careful — fluid overload worsens lung oedema)
Haemodynamic support (vasopressors in shock)
ECMO (extracorporeal membrane oxygenation) in the most severe HPS cases

Early transfer to an ICU experienced in managing respiratory failure is the most important intervention.

How to Protect Yourself

For the general public:

Do not sweep dry rodent droppings — wet them with disinfectant first, let sit 5 minutes, then remove with gloves
Seal gaps >6 mm in building walls, floors, and roofs
Use N95 respirators when cleaning enclosed spaces with evidence of rodent activity
Store food in sealed metal or glass containers

For travellers to Patagonia or Andean regions:

Avoid disturbing rodent burrows or nesting sites
Do not camp in buildings with signs of rodent activity
Report fever or muscle aches within 8 weeks of return to a physician — mention your travel history

For returning MV Hondius passengers:

Follow the WHO/national health authority 60-day monitoring protocol
Report any fever, headache, or muscle aches immediately to your monitoring physician

Key Takeaways

Hantavirus is a rodent-borne RNA virus causing HPS (Americas) or HFRS (Europe/Asia).
Person-to-person transmission occurs only with Andes virus and only in close household/care settings.
The 2026 MV Hondius cluster has produced 14 confirmed cases across 11 countries, with one confirmed P2P event in France.
R₀ ≈ 0.5 (Nature Medicine, May 15, 2026): Andes virus cannot sustain P2P chains — the pandemic risk is low.
No vaccine or antiviral exists; treatment is supportive intensive care.
Prevention centres on avoiding rodent aerosol exposure and, for Andes contacts, following updated 60-day monitoring guidance.

Sources: WHO Disease Outbreak News DON-599 (2026); ECDC Rapid Risk Assessment May 15, 2026; Nature Medicine rapid correspondence May 15, 2026; CDC HPS information.